Physician profile
Ben Hunter
NPI 1235574930
$498,698.99
in general payments reported to CMS, 2019-2025
8 companies · $196K in 2025
The $196K reported for 2025 was more than what 99% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.00 · 2021: $6,752 · 2022: $28K · 2023: $125K · 2024: $144K · 2025: $196K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $178K · Consulting Fee: $129K · Honoraria: $108K · Travel and Lodging: $40K · Food and Beverage: $8,745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $177,966.00 |
| Consulting Fee | $129,428.00 |
| Honoraria | $107,750.00 |
| Travel and Lodging | $40,323.41 |
| Food and Beverage | $8,744.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $243,336.80 | 2023-2025 | Auvelity |
| Alkermes, INC. | $228,250.38 | 2021-2025 | Lybalvi, Aristada |
| E.R. Squibb & Sons, L.L.C. | $26,645.92 | 2025 | Cobenfy |
| Janssen Pharmaceuticals, INC | $284.31 | 2019-2025 | Spravato |
| Livanova USA, INC. | $112.00 | 2023 | Vns Therapy Symmetry Model 8103 Generator |
| Abbvie INC. | $38.12 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $31.46 | 2025 | Abilify Maintena, Abilify Asimtufii |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.